Literature DB >> 31988687

Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity.

Monica Samuel Avila1, Suellen Rodrigues Rangel Siqueira1, Silvia Moreira Ayub Ferreira1, Edimar Alcides Bocchi1.   

Abstract

Recent decades have seen an increase in survival rates for cancer patients, partially explained by earlier diagnoses and new chemotherapeutic agents. However, chemotherapy may be associated with adverse cardiovascular events, including hypertension and pulmonary hypertension, supraventricular and ventricular arrhythmias, cardiomyopathy, and other forms of cardiovascular disease. For patients, the benefits of chemotherapy may be partially obfuscated by deleterious effects on the cardiovascular system, resulting in a significant increase in morbidity and mortality. In this article, we review strategies for prevention and treatment of chemotherapy-related cardiotoxicity.
© 2019 Houston Methodist Hospital Houston, Texas.

Entities:  

Keywords:  anthracyclines; cancer; cardio-oncology; cardiotoxicity; chemotherapy; heart disease; prevention; treatment

Mesh：

Substances：

Year:  2019        PMID： 31988687      PMCID： PMC6977564          DOI： 10.14797/mdcj-15-4-267

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN： 1947-6108


  52 in total

1.  Cardioprotection with dexrazoxane for doxorubicin-containing therapy in advanced breast cancer.

Authors:  S M Swain; F S Whaley; M C Gerber; S Weisberg; M York; D Spicer; S E Jones; S Wadler; A Desai; C Vogel; J Speyer; A Mittelman; S Reddy; K Pendergrass; E Velez-Garcia; M S Ewer; J R Bianchine; R A Gams
Journal:  J Clin Oncol       Date:  1997-04       Impact factor: 44.544

2.  Reversibility of trastuzumab-related cardiotoxicity: new insights based on clinical course and response to medical treatment.

Authors:  Michael S Ewer; Mary T Vooletich; Jean-Bernard Durand; Myrshia L Woods; Joseph R Davis; Vicente Valero; Daniel J Lenihan
Journal:  J Clin Oncol       Date:  2005-11-01       Impact factor: 44.544

Review 3.  Cardio-oncology: A Focus on Cardiotoxicity.

Authors:  Athanasios Koutsoukis; Argyrios Ntalianis; Evangelos Repasos; Efsthathios Kastritis; Meletios-Athanasios Dimopoulos; Ioannis Paraskevaidis
Journal:  Eur Cardiol       Date:  2018-08

4.  Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.

Authors:  Daniela Cardinale; Alessandro Colombo; Giuseppina Lamantia; Nicola Colombo; Maurizio Civelli; Gaia De Giacomi; Mara Rubino; Fabrizio Veglia; Cesare Fiorentini; Carlo M Cipolla
Journal:  J Am Coll Cardiol       Date:  2010-01-19       Impact factor: 24.094

5.  Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.

Authors:  Syed S Mahmood; Michael G Fradley; Justine V Cohen; Anju Nohria; Kerry L Reynolds; Lucie M Heinzerling; Ryan J Sullivan; Rongras Damrongwatanasuk; Carol L Chen; Dipti Gupta; Michael C Kirchberger; Magid Awadalla; Malek Z O Hassan; Javid J Moslehi; Sachin P Shah; Sarju Ganatra; Paaladinesh Thavendiranathan; Donald P Lawrence; John D Groarke; Tomas G Neilan
Journal:  J Am Coll Cardiol       Date:  2018-03-19       Impact factor: 24.094

Review 6.  Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention.

Authors:  Peter A Henriksen
Journal:  Heart       Date:  2017-12-07       Impact factor: 5.994

7.  Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes: The SUCCOUR Trial.

Authors:  Tomoko Negishi; Paaladinesh Thavendiranathan; Kazuaki Negishi; Thomas H Marwick
Journal:  JACC Cardiovasc Imaging       Date:  2018-06-13

8.  Left Ventricular Global Longitudinal Strain in HER-2 + Breast Cancer Patients Treated with Anthracyclines and Trastuzumab Who Develop Cardiotoxicity Is Associated with Subsequent Recovery of Left Ventricular Ejection Fraction.

Authors:  Hong-Wen Fei; Mohammed T Ali; Timothy C Tan; Kai-Hung Cheng; Laura Salama; Lanqi Hua; Xin Zeng; Elkan F Halpern; Alphonse Taghian; Shannon M MacDonald; Marielle Scherrer-Crosbie
Journal:  Echocardiography       Date:  2016-03-16       Impact factor: 1.724

9.  Cancer treatment and survivorship statistics, 2016.

Authors:  Kimberly D Miller; Rebecca L Siegel; Chun Chieh Lin; Angela B Mariotto; Joan L Kramer; Julia H Rowland; Kevin D Stein; Rick Alteri; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2016-06-02       Impact factor: 508.702

Review 10.  Mechanisms, monitoring, and management of tyrosine kinase inhibitors-associated cardiovascular toxicities.

Authors:  Maher Chaar; Jeff Kamta; Sihem Ait-Oudhia
Journal:  Onco Targets Ther       Date:  2018-09-25       Impact factor: 4.147
View more
  5 in total

1.  Early Detection of Cardiac Damage by Two-Dimensional Speckle Tracking Echocardiography After Thoracic Radiation Therapy: Study Protocol for a Prospective Cohort Study.

Authors:  Dan Zhu; Tingcui Li; Hongqing Zhuang; Ming Cui
Journal:  Front Cardiovasc Med       Date:  2022-01-26

2.  Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy-results from the prospective multi-center BRENDA II study.

Authors:  Elena Leinert; Lukas Schwentner; Wolfgang Janni; Achim Wöckel; Saskia-L Herbert; Daniel Herr; Thorsten Kühn; Felix Flock; Ricardo Felberbaum; Rolf Kreienberg; Visnja Fink; Davut Dayan; Kristina Ernst; Susanne Singer
Journal:  Breast Cancer       Date:  2022-02-18       Impact factor: 3.307

3.  The efficacy and safety of high-intensity interval training in chemotherapy-related cardiomyopathy: Report of two cases.

Authors:  Hee-Eun Choi; Chul Kim; Myoung-Joo Kang; Ji-Ho Park
Journal:  Turk J Phys Med Rehabil       Date:  2022-06-01

4.  Echocardiographic strategy for early detection of cardiotoxicity of doxorubicin: a prospective observational study.

Authors:  Diogo Pereira Santos Sampaio; João Batista Masson Silva; Daniela do Carmo Rassi; Aguinaldo F Freitas; Salvador Rassi
Journal:  Cardiooncology       Date:  2022-10-01

5.  Detection of the Early Cardiotoxic Effects of Doxorubicin-Containing Chemotherapy Regimens in Patients with Breast Cancer through Novel Cardiac Magnetic Resonance Imaging: A Short-term Follow-up.

Authors:  Afsaneh Maddah Safaei; Tara Molanaie Kamangar; Sanaz Asadian; Nahid Rezaeian; Ebrahim Esmati; Kasra Kolahdouzan; Leila Hosseini; Marzieh Lashkari; Fatemeh Jafari; Farnaz Amouzegar Hashemi
Journal:  J Clin Imaging Sci       Date:  2021-06-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.